Literature DB >> 24957311

Relationship between poststroke cognition, baseline factors, and functional outcome: data from "efficacy of nitric oxide in stroke" trial.

Sandeep Ankolekar1, Cheryl Renton2, Gillian Sare1, Sharon Ellender2, Nikola Sprigg3, Joanna M Wardlaw4, Philip M W Bath5.   

Abstract

BACKGROUND: Poststroke cognitive impairment is common and identification of prognostic factors associated with it and its relationship with other functional outcomes may help in developing preventative strategies.
METHODS: Previously independent patients with acute stroke, enrolled into the ongoing "Efficacy of Nitric Oxide in Stroke" trial, were assessed by telephone on day 90 for cognitive impairment using modified versions of "Mini Mental State Examination" (MMSE-M) and "Telephone Instrument for Cognitive Status" (TICS-M) scales and category fluency. The relationship of cognitive impairment with baseline prognostic factors and other functional outcomes at day 90 were studied.
RESULTS: The analysis included 1572 patients, mean age 69 years (standard deviation, 12), and female 40%. By 90 days, 246 patients had died, and cognitive impairment was present in 38%. Increasing age, stroke severity, heart rate, and presence of cerebral atrophy on baseline neuroimaging were associated with cognitive impairment (all P < .001). Hypertension and atrial fibrillation were also associated with category fluency and MMSE-M, respectively. Cognition was significantly related to other functional outcomes, TICS-M with dependency (modified Rankin Scale, rs = -.562, P < .001); disability (Barthel Index, rs = .577, P < .001); mood (Zung Depression Score, rs = -.542, P < .001); and quality of life (Euro Quality of life-5 Descriptor, rs = .519, P < .001).
CONCLUSIONS: In previously independent individuals, cognitive impairment was common 3 months after stroke and related to increasing age, stroke severity, hypertension, atrial fibrillation, and cerebral atrophy on brain scanning. Cognition was related to dependency, disability, low mood, and quality of life. Hence, treatment directed toward reducing dependency might also reduce cognitive impairment.
Copyright © 2014 National Stroke Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ENOS; Poststroke cognitive impairment; dementia; functional outcome; randomized controlled trial; stroke

Mesh:

Substances:

Year:  2014        PMID: 24957311     DOI: 10.1016/j.jstrokecerebrovasdis.2014.04.022

Source DB:  PubMed          Journal:  J Stroke Cerebrovasc Dis        ISSN: 1052-3057            Impact factor:   2.136


  17 in total

1.  Trajectory of Cognitive Decline After Incident Stroke.

Authors:  Deborah A Levine; Andrzej T Galecki; Kenneth M Langa; Frederick W Unverzagt; Mohammed U Kabeto; Bruno Giordani; Virginia G Wadley
Journal:  JAMA       Date:  2015-07-07       Impact factor: 56.272

2.  Rates, risks and routes to reduce vascular dementia (R4vad), a UK-wide multicentre prospective observational cohort study of cognition after stroke: Protocol.

Authors:  Joanna M Wardlaw; Fergus Doubal; Rosalind Brown; Ellen Backhouse; Lisa Woodhouse; Philip Bath; Terence J Quinn; Thompson Robinson; Hugh S Markus; Richard McManus; John T O'Brien; David J Werring; Nikola Sprigg; Adrian Parry-Jones; Rhian M Touyz; Steven Williams; Yee-Haur Mah; Hedley Emsley
Journal:  Eur Stroke J       Date:  2020-10-11

3.  Efficacy of nitric oxide, with or without continuing antihypertensive treatment, for management of high blood pressure in acute stroke (ENOS): a partial-factorial randomised controlled trial.

Authors: 
Journal:  Lancet       Date:  2014-10-21       Impact factor: 79.321

4.  Factors related to long-term post-stroke cognitive impairment in young adult ischemic stroke.

Authors:  Ying Huang; Shanshan Yang; Jianping Jia
Journal:  Med Sci Monit       Date:  2015-03-02

5.  Atrial Fibrillation Patients Treated With Long-Term Warfarin Anticoagulation Have Higher Rates of All Dementia Types Compared With Patients Receiving Long-Term Warfarin for Other Indications.

Authors:  T Jared Bunch; Heidi T May; Tami L Bair; Brian G Crandall; Michael J Cutler; John D Day; Victoria Jacobs; Charles Mallender; Jeffrey S Osborn; Scott M Stevens; J Peter Weiss; Scott C Woller
Journal:  J Am Heart Assoc       Date:  2016-07-11       Impact factor: 5.501

6.  Intensive versus Guideline Blood Pressure and Lipid Lowering in Patients with Previous Stroke: Main Results from the Pilot 'Prevention of Decline in Cognition after Stroke Trial' (PODCAST) Randomised Controlled Trial.

Authors:  Philip M Bath; Polly Scutt; Daniel J Blackburn; Sandeep Ankolekar; Kailash Krishnan; Clive Ballard; Alistair Burns; Jonathan Mant; Peter Passmore; Stuart Pocock; John Reckless; Nikola Sprigg; Rob Stewart; Joanna M Wardlaw; Gary A Ford
Journal:  PLoS One       Date:  2017-01-17       Impact factor: 3.240

7.  Cognitive performance after ischaemic stroke.

Authors:  Maria Gabriela R Ferreira; Carla Heloísa C Moro; Selma C Franco
Journal:  Dement Neuropsychol       Date:  2015 Apr-Jun

Review 8.  Cognitive impairment and stroke in elderly patients.

Authors:  Daniele Lo Coco; Gianluca Lopez; Salvatore Corrao
Journal:  Vasc Health Risk Manag       Date:  2016-03-24

9.  A multi-faceted knowledge translation approach to support persons with stroke and cognitive impairment: evaluation protocol.

Authors:  Sara E McEwen; Michelle Donald; Deirdre Dawson; Mary Y Egan; Anne Hunt; Sylvia Quant; Sharron Runions; Elizabeth Linkewich
Journal:  Implement Sci       Date:  2015-11-05       Impact factor: 7.327

10.  Longitudinal Effect of Stroke on Cognition: A Systematic Review.

Authors:  Eugene Yh Tang; Obreniokibo Amiesimaka; Stephanie L Harrison; Emma Green; Christopher Price; Louise Robinson; Mario Siervo; Blossom Cm Stephan
Journal:  J Am Heart Assoc       Date:  2018-01-15       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.